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To detect and characterise compounds in complex matrices, it is often necessary to
separate the compound of interest from the matrix before analysis. In our previous
work, we have developed the coupling of supercritical fluid chromatography (SFC) with
nuclear magnetic resonance (NMR) spectroscopy for the analysis of nonpolar samples
[Van Zelst et al., Anal. Chem., 2018, 90, 10457]. In this work, the SFC–NMR setup was
successfully adapted to analyse polar samples in complex matrices. In-line SFC–NMR
analysis of two N-acetylhexosamine stereoisomers was demonstrated, namely N-
acetyl-mannosamine (ManNAc) and N-acetyl-glucosamine (GlcNAc). ManNAc is
a metabolite that is present at elevated concentrations in patients suffering from NANS-
mediated disease. With our SFC–NMR setup it was possible to distinguish between the
polar stereoisomers. Until now, this was not possible with the standard mass-based
analysis techniques. The concentrations that are needed in the SFC–NMR setup are
currently too high to be able to detect ManNAc in patient samples (1.7 mM vs. 0.7 mM).
However, several adaptations to the current setup will make this possible in the future.
1 Introduction
Polar compounds make up a great part of all molecules and are of special interest
in biochemistry. They are present in biological systems, for example in biouids
such as urine. Metabolomics is an emerging eld in analytical science, which
focusses on characterising small molecules in biological systems. These metab-
olites form the (intermediate) products of biochemical reactions in our metabo-
lism. Metabolomics can be used to identify biomarkers for many diseases, such as
inborn errors of metabolism. The standard workow in untargeted metabolomics
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bInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The
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is analysis by liquid chromatography–mass spectrometry (LC-MS). In this LC-MS
workow, metabolites are rst separated and their mass-to-charge-ratio (m/z) is
determined. Thesem/z-values are then compared to databases, which oen result
in multiple hits. In this case, the chromatographic retention times and MS/MS-
fragmentation patterns will be compared to a reference compound, oen
leading to the metabolite of interest.1 However, if the structure cannot be iden-
tied in the database, more extensive analyses have to be performed.
Metabolites are very diverse in structure and functional groups, ranging from
very hydrophilic to lipophilic. Themetabolite composition also varies for different
types of biouids. In urine, very hydrophilic compounds are present, although
trace amounts of lipids and fatty acids have also been detected. Serum, on the
contrary, contains more lipids. Compared to cerebrospinal uid and saliva, urine
contains more, and more diverse metabolites. Blood contains all the metabolites
present in urine, and more, but the concentrations differ substantially. The
kidneys lter out some of the metabolites or toxins from the blood, which is why
metabolite concentrations in urine are oen higher than those in blood.2 The
chemical diversity of the compounds, along with the broad range of concentra-
tions, call for a variety of analytical techniques. Asmentioned previously, LC-MS is
generally used as the standard technique for metabolomics. Nuclear magnetic
resonance (NMR) spectroscopy, which is unbiased and can be used for a broad
range of metabolites, can be an attractive alternative. An important advantage of
using NMR spectroscopy over MS is that the technique is quantitative. However,
NMR spectroscopy is less sensitive than MS and can therefore not be used to
identify metabolites at low concentrations (typically the lower limit is around 1
mM).
Due to the complex nature of urine samples, NMR spectra are usually very
crowded and therefore especially metabolites present in lower concentrations are
difficult to identify from the spectrum. As is the case in the LC-MS workow, it
would be benecial to separate the sample into less complex fractions by chro-
matography before NMR analysis. It is however good to note that the sample gets
diluted into the mobile phase during chromatography, which can make NMR
detection difficult or even impossible. In our group, we have recently developed
a new setup, which combines supercritical uid chromatography (SFC) and NMR
spectroscopy.3 In this work we demonstrated the separation by SFC of a mixture of
tocopherol (vitamin E) isomers, followed by in-line concentration and NMR
detection. Although tocopherol is a nonpolar molecule and therefore very
different from the mostly polar molecules present in urine, we are adapting the
setup to analyse polar metabolites in urine. SFC is a type of chromatography that
uses supercritical uids, typically supercritical CO2, as the mobile phase.
Although CO2 is highly nonpolar, by adding a co-solvent to the supercritical uid,
such as methanol, the mobile phase becomes more polar. In this way, SFC is able
to separate nonpolar as well as polar compounds, making it suitable for sepa-
rating polar metabolites from urine. To be able to detect lower concentrations by
NMR spectroscopy, a method for concentrating the sample in-line aer SFC
separation has been implemented as well. This was achieved by in-line expansion
of the supercritical CO2 (scCO2), thus separating the mobile phase from the
sample during transport from the SFC outlet to the NMR probehead.
Another approach to detect smaller amounts in NMR spectroscopy is by
miniaturising the detection coil. In this way, smaller sample volumes can be
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detected at higher sensitivity. The challenge in miniaturisation is to maintain
a high resolution. Different designs have been researched, such as tightly wound
solenoid coils and planar helical coils.4–7 Our group has developed a design in
which the conventional detection coil is replaced by a high resolution at stri-
pline radio-frequency inductor. The at geometry of the stripline allows in-ow
detection, by passing a capillary over the stripline.8
To see if our SFC–NMR setup can be adapted to analyse polar samples, we
have chosen to study N-acetylhexosamines in urine as a concept application.
These monosaccharides appear in different diastereomeric forms (shown in
Fig. 1), which have equalm/z-values, and are therefore not distinguishable in the
standard HPLC-MS workow described previously. N-Acetylmannosamine
(ManNAc) is a biomarker for NANS-mediated disease, an inborn error in the
sialic acid metabolism.9 It is, however, difficult to distinguish N-ace-
tylmannosamine from its stereoisomers, N-acetylglucosamine (GlcNAc) and N-
acetylgalactosamine (GalNAc), using MS since they are equal in mass. For
identication of ManNAc in body uids, NMR spectroscopy has been
employed.9 This, however, requires relatively large amounts of sample at
a higher concentration compared to MS analyses. Martens et al. developed a new
method to study ManNAc in biouids using infrared ion spectroscopy aer
MS.10 This is a sensitive method, requiring only small amounts of sample.
However, this technique either requires a reference for comparison, or
computer simulations of the IR spectra, which do not always match the exper-
imental spectra. In our approach we will separate the compound of interest
(ManNAc) with SFC and shuttle it in-line to the NMR probehead, which is able to
detect much smaller volumes (150 nL in this case) than the standard NMR
approach (500 mL) and does not require a reference for structural character-
isation. However, sensitivity remains an issue in NMR analysis.
Due to the variations in urine samples, between different patients but also
within patients, metabolite concentrations in urine are usually expressed in mmol
per mmol creatinine. Van Karnebeek et al. found that the concentration of
ManNAc was between 41 and 98 mmol mmol1 creatinine in adult patients
suffering from NANS-mediated disease (<10 mmol mmol1 in the reference
Fig. 1 Molecular structures of the three N-acetylhexosamines. The difference in
stereochemistry between the diastereomers is indicated in red. Each diastereomer has an
a- and b-stereoisomer, indicated by the wavy bond of the alcohol group at the anomeric
carbon atom.
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sample).9 The amount of creatinine within and between patients varies enor-
mously. However according to the guidelines of the World Health Organization
(WHO), a valid urine sample ranges between 30 and 300 mg creatinine per dL
urine.11 Taking a value of 150 mg dL1 urine, the concentration of ManNAc in the
urine of patients suffering from NANS-mediated disease is estimated to be in the
range of 0.3–0.7 mM. This concentration is sufficient in a standard NMR setup,
however in our previous SFC–NMR setup we needed samples in the mM range to
be able to detect them within 50 minutes.3 A higher signal can be gained by
acquiring over a longer period of time, therefore lower concentrations may also be
detectable.
2 Experimental
2.1 Setup
The SFC–NMR setup that was used has been introduced in our previous work3 and
is shown in Fig. 2. An overview of the setup is given here; for further details the
reader is referred to our previous paper.
Fig. 2 The SFC–NMR setup (a) and detailed flow control system (b). Adapted from ref. 3.
Once a sample of interest is observed in the UV chromatogram, the first valve is switched,
letting the sample into the sample loop. When the loop is filled, the first valve switches
back. In this way, a sample plug is created in the hexane flow, which is kept at a lower
pressure. Simultaneously, the third valve switches to inject a small amount of water in the
sample plug. When the sample reaches the middle of the NMR probehead, the second
valve switches to stop the flow. In this way, multiple scans can be acquired on the same
sample, in order to increase the signal-to-noise ratio.
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The SFC is connected to the NMR probe with a ow control system. Once
a peak of interest passes the UV detector, the rst valve is switched, letting the
sample including the mobile phase into a 100 mL sample loop. When the rst
valve switches back, the sample is injected into a n-hexane (AnalaR NORMAPUR,
VWR Chemicals) ow-line, which is kept at a lower pressure than the SFC ow (60
bar compared to 120 bar). This pressure is regulated by an additional back-
pressure with an operating range between 20 and 103 bar (Vici Jour). Simulta-
neously, the third valve switches to inject 10 mL of D2O from the additional sample
loop (orange in Fig. 2b), which ends up in the middle of the sample plug. The
sample plug is transported in the hexane ow at a rate of 0.1 mL min1 from the
SFC to the NMR probe, through PEEK tubing. When the sample reaches the
middle of the NMR stripline detector, the ow can be stopped by switching valve
2. In this way, multiple scans can be acquired, to obtain a better signal-to-noise
ratio.
The three switching valves are 6-port binary-position valves (Vici Valco). A
broad ‘expansion tube’ made of stainless steel, with an inner diameter of
2.159 mm and length of 20 cm, is placed in the hexane ow line to allow for the
different phases in the sample plug to pass each other during ow. The CO2 from
the trailing edge of the plug can then go past the methanol to the beginning of the
plug. All PEEK tubing used in the system has an inner diameter of 0.508 mm,
except for the tubing from the ‘expansion tube’ to the NMR probe, which has an
inner diameter of 0.254 mm. In the stripline probe, a fused silica capillary with an
inner diameter of 250 mm and outer diameter of 360 mm (Polymicro Technologies)
transports the sample over the active detection volume of the chip. Aer the
experiment, the sample ows back from the NMR spectrometer, over the addi-
tional backpressure regulator, to the waste.
2.2 Instruments
In the SFC–NMR setup, a Waters Acquity UPC2 instrument was coupled to a Var-
ian VNMRS spectrometer at 600 MHz Larmor frequency (14.1 T). A home-built
stripline probe was used,8 with a 600 mm wide and 5 mm long chip with split
contacts, with an active detection volume of 150 nL. In-ow experiments were
performed with a relaxation delay of 0.2 s and an acquisition time of 0.5 s (in total
0.7 s per spectrum), while stop-ow experiments and the three reference spectra
were acquired with a relaxation delay of 10 s and an acquisition time of 1 s. All
spectra were recorded with a receiver bandwidth of 10 kHz. The spectra are
referenced to the water peak, which was set to 4.79 ppm. All spectra were pro-
cessed using the ssNake soware package.12
2.3 SFC chromatography
For the SFC optimisation, in Fig. 3, a sample of 0.78 M N-acetyl-D-mannosamine
(>98%, Sigma Aldrich) in ultra pure water was prepared. For the separation in
Fig. 4, a sample of 0.035 M N-acetyl-D-mannosamine was dissolved in synthetic
urine (Surine Negative Urine Control, Cerilliant, Sigma Aldrich). In both cases, 0.5
mL of the sample was injected onto a 100 mm  1.7 mm packed 2-PIC SFC column
(Waters) at a backpressure of 120 bar, a ow rate of 1.5 mL min1 and
a temperature of 60 C. For the optimal separation, an isocratic mobile phase of
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30% methanol (BioSolve, SFC grade) in CO2 (Linde Gas Benelux, food grade) was
used. All UV chromatograms were recorded at a wavelength of 210 nm.
2.4 (SFC–)NMR
The 1H NMR reference spectra were obtained by dissolving N-acetylglucosamine,
N-acetyl-D-mannosamine (>98%) and N-acetyl-D-galactosamine (98%) (all from
Sigma Aldrich) in deuterated water (99.9%; Sigma Aldrich) at concentrations of
0.38 M, 0.38 M and 0.75 M, respectively. The samples were then inserted
Fig. 3 UV chromatogram of the SFC separation of ManNac in water (0.78 M, 0.5 mL
injection volume) on a 2-PIC column (Waters) at 60 C, 120 bar and a flow rate of 1.5
ml min1. The top graph was separated with a mobile phase of 30%MeOH in CO2, and the
bottom graph with 20% MeOH in CO2. The sharpest peak is obtained with 30% MeOH in
CO2.
Fig. 4 UV chromatogram of the SFC separation of ManNac in Surine (top) (0.035 M, 0.5 mL
injected volume) and pure Surine (bottom) on a 2-PIC column at 60 C, 120 bar and a flow
rate of 1.5 ml min1 for a mobile phase of 30%MeOH in CO2. A small impurity of a previous
separation is present in the chromatogram of pure Surine. Under these conditions,
ManNAc can be separated from synthetic urine.
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separately into a 15 cm long, 250 mm I.D./350 mm O.D. fused silica capillary by
capillary suction, which was then sealed at both ends with optical glue. The three
reference spectra were acquired using a stripline probe employing a relaxation
delay of 10 s and an acquisition time of 1 s, and summing over 6400 scans (19 h 33
min), 13 600 scans (41 h 33 min) and 1500 scans (4 h 35 min), respectively.
For the SFC–NMR spectra, a ManNAc sample of 0.78 M and a GlcNAc sample of
0.73 M in ultra pure water were used, of which 4 mL was injected onto the SFC
column (further details in the previous section). The 1H NMR spectra were
acquired under the same conditions as the reference spectra, but this time
averaging over 4860 scans (14 h 51 min) and 3520 scans (10 h 45 min) for ManNAc
and GlcNAc, respectively.
3 Results and discussion
In this research, ManNAc in urine was chosen as a concept application to develop
the SFC–NMR setup for polar samples. First, the SFC separation will be optimised
for ManNAc in urine. Then, a method for in-line concentration of the sample will
be discussed, which is needed to be able to detect the analyte by NMR spectros-
copy. Finally, the SFC–NMR analysis of ManNAc (and its stereoisomers) is
demonstrated.
3.1 SFC of N-acetylhexosamines in synthetic urine
During the optimisation of the SFC separation of ManNAc from urine, we have
worked with synthetic urine to eliminate sample variation between batches. Later
on, this research could be extended to real urine samples. Several stationary
phases were investigated for the SFC separation of ManNAc (BEH, BEH 2-EP and
2-PIC columns from Waters), of which the 2-PIC column showed the best results.
The next parameter under investigation was the mobile phase composition.
Methanol can be mixed with CO2 order to make the mobile phase more polar. In
Fig. 3, the elutions of ManNAc in water from a 2-PIC SFC column with mobile
phases containing 20% and 30% methanol in CO2 are shown. It is clear that the
retention of ManNAc decreases with the increase in the polarity of the mobile
phase, which was expected. For 30% methanol, the peak is much sharper. Using
a higher concentration of methanol decreases the retention time further and an
even sharper peak is obtained. However, 30% methanol in CO2 was chosen as the
optimum, since a higher methanol volume means that the sample will be more
diluted in the NMR analysis.
With these optimised parameters, the separation of ManNAc from synthetic
urine was performed. In Fig. 4, the UV chromatogram of the SFC separation of
ManNAc in synthetic urine, on a 2-PIC column with a mobile phase of 30%
methanol in CO2, is shown. The optimised parameters give a clear separation of
ManNAc from synthetic urine. Due to this, the peak fromManNAc can be selected
separately from the sample matrix for the SFC–NMR analysis.
3.2 In-line concentration by expansion of scCO2
Since the sample gets diluted in the mobile phase during SFC, it is difficult to
detect this low concentration by NMR spectroscopy. This is why concentrating the
sample, preferably in-line, aer chromatography is required.
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In our previous work we have demonstrated that by expanding the sample plug
in-line in a controlled fashion, the sample and co-solvent are separated from the
mobile phase, CO2.3 In this way, the sample is concentrated in a smaller volume,
which leads to a higher concentration, which is needed for NMR detection. This
method will be employed here as well. However, in our previous work, our
transportation medium was water, which did not mix with the nonpolar samples
that were investigated. If water is used as the transportation medium in the case
of polar samples, the compound will dissolve into the water, thus diluting the
sample even more. This is why an alternative, nonpolar transportation solvent
was chosen in this work, namely hexane. The sample plug, including CO2 and co-
solvent methanol, is injected into the hexane ow through a valve switching
system, and is transported to the NMR probehead. By keeping the hexane ow at
a lower pressure, the plug is expected to expand and the sample and co-solvent
will separate from the CO2.
Under the same conditions as employed in our previous work (hexane ow-line
at 50 bar, injection of the sample plug at 120 bar), however, no phase separation
occurred. No dened sample plug was observed. This was due to the mixing of
hexane with CO2, which both have a similar polarity. Due to this mixing, the
expansion did not take place at a pressure of 50 bar. Several pressures were inves-
tigated, aer which it was found that the sample andmethanol co-solvent separated
best from the CO2 at a pressure of 60 bar for the hexane ow-line. Additionally, it
was found that methanol has a strong affinity for the tubing walls, which are made
out of PEEK (polyether ether ketone). Most of the methanol in the sample plug, and
with it the sample, will stick to the tubing and will therefore not reach the NMR
detector. In order to transport themethanol in the sample plug to the NMR probe, it
is necessary to inject a small volume of water into the sample plug, which collects
the methanol and sample and allows them to reach the NMR probe.
To follow the phase separation in the plug in-ow, NMR spectra were recorded
each 0.7 s of an expanding mixture of 30%MeOH in CO2. 100 mL of this mixture at
120 bar, to which 10 mL D2O is added later on, is injected in the hexane ow-line at
60 bar. The sample plug, as observed in the NMR probe, is shown in Fig. 5. In this
gure, the methyl peak of hexane (the transportation medium) and the methyl
peak of methanol (part of the plug) were integrated separately in each of the NMR
spectra and plotted over time.
The most important result is that methanol and water are mainly collected at
the trailing edge of the plug. When a polar sample is present, this will dissolve in
methanol and water, not in hexane or CO2. When the pressure is kept at 120 bar
instead of 60 bar, the methanol spreads out over the entire plug (1.55 min until
2.3 min), since it stays dissolved in the CO2. Without the expansion to 60 bar, the
volume in which the sample is dissolved is much larger than when the CO2 is
separated from the methanol, namely approximately 110 mL (CO2, D2O and
MeOH) of 40 mL (D2O andMeOH). From Fig. 5, it can be seen that most of the CO2
is separated from the methanol and therefore the concentration method by in-
line expansion is successful. It can be seen, however, that a small amount of
methanol is not collected at the trailing edge of the plug, but remains dissolved in
the CO2 at the start of the plug (1.6–2.0 min). This means that a small part of the
sample will not be collected at the end, but will remain spread out over this part of
the plug. This loss is, however, quite small, since most of the sample will be
concentrated at the end.
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Another interesting phenomenon is that hexane from the ow starts mixing in
with CO2 at the beginning of the plug. This is due to the fact that hexane and CO2
have a similar polarity. At the trailing edge of the plug, this mixing does not occur
since (almost) no CO2 is present in the highly concentrated methanol. However,
a very small amount of hexane is present also in the methanol, probably due to
the presence of a small remainder of CO2 in which the hexane can dissolve. This
will be visible in the SFC–NMR spectra.
The in-line concentration method, which is performed by expanding the sample
plug in-line to 60 bar and adding a small amount of water to collect the methanol,
can be used successfully for polar samples. However, a small sample loss might
occur due to the fact that a small amount ofmethanol remains dissolved in the CO2
and some methanol sticks to the tubing walls during transportation of the sample
to the NMR probe. A small amount of hexanemay also be observed in the SFC–NMR
spectra that are recorded at the trailing edge of the plug, due to mixing of hexane
with a small remainder of CO2 in the concentrated methanol.
3.3 Stripline NMR analysis of N-acetylhexosamines
To show that NMR spectroscopy is able to distinguish between the different
isomers ManNAc, GlcNAc and GalNAc, reference 1H NMR spectra were acquired
for these three compounds in deuterated water. The three spectra were acquired
in the same stripline probe as was used for the in-ow SFC–NMR experiments.
The samples were measured in sealed off capillaries. The three spectra are plotted
in Fig. 6.
It can be seen that the different diastereomers have different 1H NMR spectra.
This is due to the stereochemistry of the molecules. The chemical shi of a proton
depends on its chemical environment. When an alcohol group or the amine
Fig. 5 Sample plug of 30%MeOH in CO2 injected in a hexane flow,measured in-flow after
in-line expansion to 60 bar. 1H NMR spectra were acquired every 0.7 s during the flow of
the sample from the SFC towards the NMR probehead. The methyl peaks of hexane (blue)
and methanol (orange) were integrated separately in each spectrum over time and nor-
malised to the maximummethanol integral to give the graphs. A polar sample will dissolve
in methanol/water and will therefore mainly be concentrated in the trailing edge of the
plug.
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group ips from the top to the bottom of the ring, the chemical environment of
the proton attached to that group, but also of the surrounding protons, will
change and with it their chemical shis change. Between the three isomers, the
stereochemistry of proton 2 and proton 4 is different, which is observed as a shi
in the spectra. As explained before, however, the shis of the other protons also
change. An interesting observation, especially for the spectra of ManNAc and
GlcNAc, is that many of the peaks come in pairs. This is due to the fact that within
the molecule the alcohol group next to the heteroatom in the ring can change in
axial/equatorial position, between a-ManNAc and b-ManNAc. Although the
reference compounds that were purchased were 98% pure, in water the position
of this alcohol group can change. Also, it can be seen that a small ManNAc
contamination is present in the GlcNAc reference spectrum, since all of the peaks
match, but are present at much lower intensities.
These reference spectra were acquired at a high concentration, averaging over
a substantial number of scans to obtain a high signal-to-noise ratio. For the SFC–
NMR analysis, the concentrations will be lower. The most intense peak will be the
peak that can be detected in the least amount of time at lower concentrations. In
this case, this will be the peak at 2.0 ppm, corresponding to the CH3 group.
However, this peak has the same chemical shi for all three diastereomers and
cannot be used to distinguish them. The peak around 5.1 ppm (proton 1) will
therefore be the best to make a distinction between the three isomers.
3.4 SFC–NMR analysis of ManNAc and GlcNAc
In the previous sections, the SFC separation was optimised for separating Man-
NAc from water or synthetic urine and it was shown that a distinction between the
isomers can be made by looking at the 1H NMR spectra. In this section, these two
Fig. 6 1H NMR spectra of GalNac (0.75 M), GlcNAc (0.38 M) and ManNAc (0.38 M) in D2O
(from top to bottom), acquired using the stripline NMR probe. The spectra were scaled to
the integrals of the peak(s) around 2 ppm. The structure of ManNAc is shown in the figure
for assignment of the peaks. An asterisk (*) next to the peak number indicates the
difference between the a- and b-isomer of the same molecule. A full assignment of the
spectra can also be found in the Human Metabolome Database (HMDB).13
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techniques will be combined in-line to obtain an SFC–NMR analysis of these polar
stereoisomers. For this, 4 mL of ManNAc (0.78 M) and GlcNAc (0.73 M) in water
were injected for SFC separation. The chromatograms can be found in the ESI
(S1).† 100 mL of the peak of interest was selected through a valve switching system
in a sample loop. 10 mL of D2O was injected in the middle of this sample loop. The
whole plug was then placed into a hexane ow-line at a pressure of 60 bar and
transported to the middle of the NMR stripline probe. There, the ow was stopped
and multiple scans (taking 10 h 45 min for GlcNAc and 14 h 51 min for ManNAc)
were acquired to obtain the SFC–NMR spectra shown in Fig. 7. The reference 1H
NMR spectrum, already shown in Fig. 6, of each corresponding isomer is shown
under each SFC–NMR spectrum for comparison.
From the SFC–NMR analysis it can be seen that the different stereoisomers can
be distinguished, especially by the peak around 5.1 ppm, corresponding to proton
1 on the anomeric carbon atom next to the heteroatom in the ring. ManNAc can
also be identied by the peak around 4.3 ppm, which is not present at this shi
for the other two stereoisomers and corresponds to the proton at the carbon atom
to which the amine group is attached. Some chemical shis are slightly different
in the SFC–NMR spectra compared to the reference spectra. This is due to the
solvent, since the reference spectra were measured in D2O while the SFC–NMR
spectra have a 1 : 3 ratio of D2O and methanol as the solvent. The latter comes
from the SFC separation, since 30%methanol is used as the co-solvent. The water
peak at 4.79 ppm and the methanol peak, here at 3.3 ppm, are therefore quite
substantial in the spectra. D2O exchanges protons with the non-deuterated
methanol, therefore the residual water peak is more intense than usual. A solu-
tion to this would be to use deuterated methanol, but this would be quite
expensive since the whole SFC separation would have to be performed with
MeOD. However, in the SFC–NMR spectra shown, the solvent peaks do not
overlap too much with the peaks of interest. Two extra peaks are present at 0.8
and 1.2 ppm (not shown), which originate from the small amount of hexane that
Fig. 7 SFC-1H NMR spectra of GlcNAc (bottom) and ManNAc (top) in D2O and MeOH,
compared to their respective 1H NMR reference spectra (shown before in Fig. 6). The
spectra were scaled to the integrals of the peak(s) around 2 ppm. A Lorentzian line
broadening of 1.5 Hz was applied to the SFC–NMR spectra. The distinction between the
two isomers is clearly visible in the SFC–NMR spectra.
Paper Faraday Discussions
This journal is © The Royal Society of Chemistry 2019 Faraday Discuss., 2019, 218, 219–232 | 229
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
3 
Ja
nu
ar
y 
20
19
. D
ow
nl
oa
de
d 
on
 2
/1
9/
20
20
 1
:1
7:
20
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
is still present in the sample plug (discussed in the previous section). These are,
however, low in intensity, namely about the same intensity as the peak at 2.0 ppm,
and do not overlap with the peaks of interest. If this causes a problem in the
analysis of other compounds, an alternative might be to use uorinated hexane as
the transportation medium, which will not be visible in the 1H NMR spectra.
An interesting feature is the presence of the a- and b-stereoisomers. As can be
seen in the gure, the ratios between these two are different in the SFC–NMR
spectra compared to the reference spectra. This may have different causes. First,
the SFC–NMR spectra contain more methanol than water, which might inuence
the transition from one stereoisomer into the other. Second, due to the SFC
separation, only one part of the peak is selected, which possibly contains only one
isomer. However, it would still be expected that the selected isomer transfers into
the other stereoisomer, but the timescale of the transition might be longer than
the time in which the SFC–NMR analysis took place. This is, however, less likely,
due to the long timescale of the experiment.
An important point of interest is to see if this method will be a viable analysis
technique for metabolites in urine. For ManNAc, the SFC–NMR analysis started
with a 4 mL injection of a sample with a high concentration (0.78 M). The chro-
matogram of this separation is shown in the ESI (S1).† Although the concentra-
tion is high, the amount injected on the column is then only 3.1 mmol. Of this 3.1
mmol, only a part is selected for transportation towards the NMR spectrometer.
Since the UV detector was overloaded due to the high concentration that was
injected, it is not possible to determine which fraction of the peak was injected. It
is, however, possible to determine this from the NMR spectra, since these are
quantitative. By comparing the integral of the reference spectrum with a known
concentration (0.35 M) to the integral of the SFC–NMR spectrum and correcting
for the number of scans, it can be concluded that the ManNAc concentration in
the SFC–NMR spectrum is 15 mM. The signal-to-noise (S/N) ratio of the peak at
5.1 ppm is higher than necessary, therefore a lower concentration can be handled.
If the minimum S/N-ratio in the spectrum is set to 3, the concentration could be
lowered from 15 mM to 1.7 mM. As determined in the introduction, the
concentration of ManNAc in the urine of patients suffering from NANS-mediated
disease is estimated to be in the range of 0.3–0.7 mM. This is a factor 2.5–5.5 lower
than we can currently detect. One of the solutions to this problem is using a larger
volume stripline detector. The volume in which our sample is dissolved is 40 mL,
however our current NMR probe has an active detection volume of 150 nL. A
signicant fraction of the sample is therefore not detected. By scaling up the
stripline probe by a factor of 10 to 1.5 mL detection volume, a gain of a factor 5 in
concentration can be achieved,14 or a decrease of a factor 25 in experimental time
at equal concentration. This will be enough to be able to detect ManNAc in the
urine of patients suffering from NANS-mediated disease. Such a large-volume
stripline probe is under development.
The calculations above were made assuming that there is no sample loss in the
system. The concentration in the SFC–NMR spectrum of ManNAc was determined
to be 15 mM. This corresponds to 0.61 mmol in 40 mL of solvent (10 mL D2O and 30
mL MeOH). The entire peak in the SFC chromatogram consisted of 3.1 mmol, of
which only a fraction was sent to the NMR spectrometer. If we assume that half of
the peak is selected, meaning 1.5 mmol is sent to the NMR detector, this indicates
that more than half of the sample gets lost during transport. Probably this sticks
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to the tubing walls, since methanol binds strongly to the PEEK tubing which
couples the SFC machine to the spectrometer. Changing the tubing material to
a less hydrophilic material may help in getting a higher concentration to the NMR
probe and reducing sample losses during transportation.
4 Conclusions
Our SFC–NMR setup was successfully adapted to analyse polar samples in
complex matrices. By controlled expansion of the scCO2, the sample coming from
the chromatograph can be concentrated in-line. Concentrating the sample in-line
aer chromatography is needed to detect the sample with NMR spectroscopy.
SFC separation of N-acetylhexosamine stereoisomers from synthetic urine was
optimised, using a 2-PIC column (Waters) as the stationary phase and 30%
MeOH/CO2 as the mobile phase. Aer this, in-line SFC–NMR analysis of two N-
acetylhexosamine isomers, namely N-acetyl-mannosamine (ManNAc) and N-
acetyl-glucosamine (GlcNAc), was demonstrated. ManNAc is a metabolite that is
present at elevated concentrations in patients suffering from NANS-mediated
disease. With the SFC–NMR setup it is possible to distinguish between these
polar stereoisomers. This is not possible with the current standard analysis
techniques, which are based on mass detection.
The concentrations that are needed in the SFC–NMR setup are currently too
high to be able to detect ManNAc in patient samples (1.7 mM vs. 0.7 mM) in
a reasonable time. However, several adaptations to the current setup will make this
possible. First, the detection volume of the stripline NMR probe needs to be
increased by a factor 10 to better match the sample volumes coming from the
chromatograph. It will then be possible tomeasure concentrations around 0.3mM.
Second, the tubing connecting the SFC to the NMR probe needs to be replaced with
a less hydrophilic material, to decrease sample losses during transportation of the
sample towards the NMR spectrometer.With these adaptations it will be possible to
detect ManNAc in urine samples from patients suffering from NANS-mediated
disease with in-line SFC–NMR. Due to the broad separation range of SFC and its
coupling to NMR spectroscopy, it is expected that other polar and non-polar
metabolites present at these, or higher, concentrations in biouids can also be
analysed with the same setup. By tuning the polarity of themobile phase, SFC–NMR
can be used to analyse a broad range of hydrophilic and lipophilic metabolites.
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